TIGD7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.590310E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.002800E-01
Normal-vs-Stage2
6.463000E-03
Normal-vs-Stage3
1.421180E-01
Normal-vs-Stage4
4.148400E-01
Stage1-vs-Stage2
2.575200E-01
Stage1-vs-Stage3
1.404610E-01
Stage1-vs-Stage4
9.095400E-01
Stage2-vs-Stage3
2.725400E-01
Stage2-vs-Stage4
2.525200E-01
Stage3-vs-Stage4
2.318600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.136300E-02
Normal-vs-AfricanAmerican
2.063900E-02
Normal-vs-Asian
4.116300E-02
Caucasian-vs-AfricanAmerican
2.233600E-01
Caucasian-vs-Asian
2.314200E-01
AfricanAmerican-vs-Asian
8.010000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.176700E-03
Normal-vs-Female
4.033900E-02
Male-vs-Female
3.521600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.025200E-01
Normal-vs-Age(41-60Yrs)
3.857800E-02
Normal-vs-Age(61-80Yrs)
1.419940E-02
Normal-vs-Age(81-100Yrs)
6.481900E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.391170E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.871600E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.820500E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.099600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.202100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.247600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.215710E-02
Normal-vs-Daily Drinker
9.004700E-03
Normal-vs-Weekly Drinker
9.136100E-03
Normal-vs-Occasional Drinker
2.338600E-01
Normal-vs-Social Drinker
2.703200E-01
Non Drinker-vs-Daily Drinker
9.281600E-01
Non Drinker-vs-Weekly Drinker
9.841600E-01
Non Drinker-vs-Occasional Drinker
3.828200E-02
Non Drinker-vs-Social Drinker
6.139600E-02
Daily Drinker-vs-Weekly Drinker
9.161600E-01
Daily Drinker-vs-Occasional Drinker
5.053900E-02
Daily Drinker-vs-Social Drinker
7.738300E-02
Weekly Drinker-vs-Occasional Drinker
7.106000E-02
Weekly Drinker-vs-Social Drinker
9.939600E-02
Occasional Drinker-vs-Social Drinker
9.768200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.771800E-01
Normal-vs-Grade 2
2.751200E-01
Normal-vs-Grade 3
2.421400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.730200E-01
Grade 1-vs-Grade 3
7.321000E-01
Grade 1-vs-Grade 4
3.771800E-01
Grade 2-vs-Grade 3
3.677200E-01
Grade 2-vs-Grade 4
2.751200E-01
Grade 3-vs-Grade 4
2.421400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.160100E-03
Normal-vs-NonDiabetic
1.967960E-02
Diabetic-vs-NonDiabetic
3.503200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.955300E-03
Normal-vs-NoPancreatitis
1.929850E-02
Pancreatitis-vs-NoPancreatitis
1.725370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.133700E-02
Normal-vs-N1
6.015400E-03
N0-vs-N1
8.492800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.750200E-01
Normal-vs-TP53-NonMutant
1.714150E-01
TP53-Mutant-vs-TP53-NonMutant
1.542350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
